United States Patent and Trademark Office OG Notices: 25 September 2007
Summary of Final Decisions Issued by the Trademark Trial and Appeal Board August 20-24, 2007 Date Type of Proceeding Issued Case (1) or App'n No. Party/Parties 8-20 OPP 91161603 Allergan, Inc. v. BioCentric Laboratories, Inc. Opposer's/ Applicant's/ Petitioner's Respondent's TTAB Mark and Mark and Issue Decision Goods/Services Goods/Services 2(d) Opposition "BOTOX" "SEATOX" Sustained [pharmaceutical [cosmetics] preparations, namely, ophthalmic muscle relaxants; pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain] Mark and Citable as Goods Cited by Precedent Examining Atty. of TTAB No (1)EX=EX PARTE APPEAL; OPP=OPPOSITION; CANC=CANCELLATION; CU=CONCURRENT USE; (SJ)=SUMMARY JUDGMENT; (R)=REQ. FOR RECONSIDERATION; (MD)=MOTION TO DISMISS; (MR)=MOTION TO REOPEN